BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26995561)

  • 1. Quantifying clinical change: discrepancies between patients' and providers' perspectives.
    Dreyer RP; Jones PG; Kutty S; Spertus JA
    Qual Life Res; 2016 Sep; 25(9):2213-20. PubMed ID: 26995561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction.
    Butler J; Khan MS; Mori C; Filippatos GS; Ponikowski P; Comin-Colet J; Roubert B; Spertus JA; Anker SD
    Eur J Heart Fail; 2020 Jun; 22(6):999-1005. PubMed ID: 32239794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.
    Watanabe-Fujinuma E; Origasa H; Bamber L; Roessig L; Toyoda T; Haga Y; Gwaltney C; Pieske B
    Health Qual Life Outcomes; 2020 Jul; 18(1):236. PubMed ID: 32680513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.
    Khariton Y; Hernandez AF; Fonarow GC; Sharma PP; Duffy CI; Thomas L; Mi X; Albert NM; Butler J; McCague K; Nassif ME; Williams FB; DeVore A; Patterson JH; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004668. PubMed ID: 29627798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial.
    Sandhu AT; Calma J; Skye M; Kalwani N; Zheng J; Schirmer J; Din N; Brown Johnson C; Gupta A; Lan R; Yu B; Spertus JA; Heidenreich PA
    Circulation; 2024 May; 149(22):1717-1728. PubMed ID: 38583147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Patient-Reported Outcome Measurement in Heart Failure Clinic on Clinician Health Status Assessment and Patient Experience: A Substudy of the PRO-HF Trial.
    Sandhu AT; Zheng J; Kalwani NM; Gupta A; Calma J; Skye M; Lan R; Yu B; Spertus JA; Heidenreich PA
    Circ Heart Fail; 2023 Feb; 16(2):e010280. PubMed ID: 36334312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
    Filippatos G; Maggioni AP; Lam CSP; Pieske-Kraigher E; Butler J; Spertus J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Bamber L; Gheorghiade M; Pieske B
    Eur J Heart Fail; 2017 Jun; 19(6):782-791. PubMed ID: 28586537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.
    Luo N; O'Connor CM; Cooper LB; Sun JL; Coles A; Reed SD; Whellan DJ; PiƱa IL; Kraus WE; Mentz RJ
    Eur J Heart Fail; 2019 Jan; 21(1):63-70. PubMed ID: 30168635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in the clinical status of patients with advanced heart failure.
    Hauptman PJ; Masoudi FA; Weintraub WS; Pina I; Jones PG; Spertus JA;
    J Card Fail; 2004 Oct; 10(5):397-402. PubMed ID: 15470650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between the Kansas City Cardiomyopathy Questionnaire and New York Heart Association in Assessing Functional Capacity and Clinical Outcomes.
    Hawwa N; Vest AR; Kumar R; Lahoud R; Young JB; Wu Y; Gorodeski EZ; Cho L
    J Card Fail; 2017 Apr; 23(4):280-285. PubMed ID: 27940335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.
    Green CP; Porter CB; Bresnahan DR; Spertus JA
    J Am Coll Cardiol; 2000 Apr; 35(5):1245-55. PubMed ID: 10758967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes in Patients with Cardiomyopathy.
    Garcia RA; Benton MC; Spertus JA
    Curr Cardiol Rep; 2021 Jun; 23(7):91. PubMed ID: 34121150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Implementation of Patient-Reported Outcomes in Heart Failure Clinic: A Qualitative Assessment.
    Brown-Johnson C; Calma J; Amano A; Winget M; Harris SR; Vilendrer S; Asch SM; Heidenreich P; Sandhu AT; Kalwani NM
    Circ Cardiovasc Qual Outcomes; 2023 May; 16(5):e009677. PubMed ID: 37114990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial.
    Lewis EF; Kim HY; Claggett B; Spertus J; Heitner JF; Assmann SF; Kenwood CT; Solomon SD; Desai AS; Fang JC; McKinlay SA; Pitt BA; Pfeffer MA;
    Circ Heart Fail; 2016 Mar; 9(3):e001937. PubMed ID: 26962133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing responsiveness of generic and specific health related quality of life measures in heart failure.
    Eurich DT; Johnson JA; Reid KJ; Spertus JA
    Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.
    Sauser K; Spertus JA; Pierchala L; Davis E; Pang PS
    J Card Fail; 2014 Jan; 20(1):18-22. PubMed ID: 24296380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock's clinical score in predicting heart failure outcomes.
    Sawadogo K; Ambroise J; Vercauteren S; Castadot M; Vanhalewyn M; Col J; Robert A
    Qual Life Res; 2016 May; 25(5):1245-55. PubMed ID: 26456163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patient-reported outcome measurement in heart failure clinic trial: Rationale and methods of the PRO-HF trial.
    Kalwani NM; Calma J; Varghese GM; Gupta A; Zheng J; Brown-Johnson C; Amano A; Vilendrer S; Winget M; Asch SM; Heidenreich P; Sandhu A
    Am Heart J; 2023 Jan; 255():137-146. PubMed ID: 36309127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burdensome Physical and Depressive Symptoms Predict Heart Failure-Specific Health Status Over One Year.
    Lum HD; Carey EP; Fairclough D; Plomondon ME; Hutt E; Rumsfeld JS; Bekelman DB
    J Pain Symptom Manage; 2016 Jun; 51(6):963-70. PubMed ID: 26921492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.